Literature DB >> 26260736

Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Benjamin I Goldstein, Mercedes R Carnethon, Karen A Matthews, Roger S McIntyre, Gregory E Miller, Geetha Raghuveer, Catherine M Stoney, Hank Wasiak, Brian W McCrindle.   

Abstract

In the 2011 "Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents," several medical conditions among youth were identified that predispose to accelerated atherosclerosis and early cardiovascular disease (CVD), and risk stratification and management strategies for youth with these conditions were elaborated. Major depressive disorder (MDD) and bipolar disorder (BD) among youth satisfy the criteria set for, and therefore merit inclusion among, Expert Panel tier II moderate-risk conditions. The combined prevalence of MDD and BD among adolescents in the United States is ≈10%, at least 10 times greater than the prevalence of the existing moderate-risk conditions combined. The high prevalence of MDD and BD underscores the importance of positioning these diseases alongside other pediatric diseases previously identified as moderate risk for CVD. The overall objective of this statement is to increase awareness and recognition of MDD and BD among youth as moderate-risk conditions for early CVD. To achieve this objective, the primary specific aims of this statement are to (1) summarize evidence that MDD and BD are tier II moderate-risk conditions associated with accelerated atherosclerosis and early CVD and (2) position MDD and BD as tier II moderate-risk conditions that require the application of risk stratification and management strategies in accordance with Expert Panel recommendations. In this scientific statement, there is an integration of the various factors that putatively underlie the association of MDD and BD with CVD, including pathophysiological mechanisms, traditional CVD risk factors, behavioral and environmental factors, and psychiatric medications.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; adolescent; atherosclerosis; bipolar disorder; cardiovascular diseases; coronary artery disease; depressive disorder, major; population at risk

Mesh:

Year:  2015        PMID: 26260736     DOI: 10.1161/CIR.0000000000000229

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  117 in total

1.  Depressive Symptoms, Antidepressant Use, and Hypertension in Young Adulthood.

Authors:  Danielle M Crookes; Ryan T Demmer; Katherine M Keyes; Karestan C Koenen; Shakira F Suglia
Journal:  Epidemiology       Date:  2018-07       Impact factor: 4.822

2.  Cardiac vagal control mediates the relation between past depression and blood pressure several years later among young adults.

Authors:  Xiao Yang; Shimrit Daches; Ilya Yaroslavsky; Charles J George; Maria Kovacs
Journal:  Psychophysiology       Date:  2020-01-27       Impact factor: 4.016

3.  High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder.

Authors:  Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A Axelson; Daniel P Dickstein; Tina R Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D Ryan; Michael A Strober; Martin B Keller; Benjamin I Goldstein
Journal:  J Clin Psychiatry       Date:  2019-07-30       Impact factor: 4.384

Review 4.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

5.  Bipolar disorder and related mood states are not associated with endothelial function of small arteries in adults without heart disease.

Authors:  Brian Tong; Oluchi Abosi; Samantha Schmitz; Janie Myers; Gary L Pierce; Jess G Fiedorowicz
Journal:  Gen Hosp Psychiatry       Date:  2017-12-19       Impact factor: 3.238

6.  Acute stress response to a cognitive task in patients with major depressive disorder: potential metabolic and proinflammatory biomarkers.

Authors:  Tatiana Druzhkova; Ksenia Pochigaeva; Aleksander Yakovlev; Evdokia Kazimirova; Maria Grishkina; Aleksey Chepelev; Alla Guekht; Natalia Gulyaeva
Journal:  Metab Brain Dis       Date:  2018-12-18       Impact factor: 3.584

7.  Relationships of Anxiety and Depression with Cardiovascular Health in Youth with Normal Weight to Severe Obesity.

Authors:  Amy C Gross; Alexander M Kaizer; Justin R Ryder; Claudia K Fox; Kyle D Rudser; Donald R Dengel; Aaron S Kelly
Journal:  J Pediatr       Date:  2018-05-10       Impact factor: 4.406

Review 8.  Post-traumatic stress disorder and cardiometabolic disease: improving causal inference to inform practice.

Authors:  K C Koenen; J A Sumner; P Gilsanz; M M Glymour; A Ratanatharathorn; E B Rimm; A L Roberts; A Winning; L D Kubzansky
Journal:  Psychol Med       Date:  2016-10-04       Impact factor: 7.723

9.  Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression.

Authors:  Karim Malki; Maria Grazia Tosto; Héctor Mouriño-Talín; Sabela Rodríguez-Lorenzo; Oliver Pain; Irfan Jumhaboy; Tina Liu; Panos Parpas; Stuart Newman; Artem Malykh; Lucia Carboni; Rudolf Uher; Peter McGuffin; Leonard C Schalkwyk; Kevin Bryson; Mark Herbster
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-01       Impact factor: 3.568

Review 10.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.